AVITA Medical, Inc. (RCEL) FCF Margin (2019 - 2025)

AVITA Medical (RCEL) has reported FCF Margin for 7 consecutive years, with 5.18% the latest figure, recorded in Q4 2025.

• For the quarter ending Q4 2025, FCF Margin rose 4727.0% year-over-year to 5.18%; the trailing twelve-month figure through Dec 2025 stood at 22.06% (up 6832.0% YoY), and the FY2025 full-year result was 44.97%, up 4541.0% from the prior year.
• FCF Margin improved to 5.18% in Q4 2025 per RCEL's latest filing, from 36.06% in the prior quarter.
• Across five years, FCF Margin topped out at 79.65% in Q4 2022 and bottomed at 198.23% in Q1 2024.
• Historically, FCF Margin has averaged 68.04% across 5 years, with a median of 69.45% in 2023.
• The sharpest annual moves came in 2023 and 2025: FCF Margin sank 15826 bps in 2023, then jumped 14394 bps in 2025.
• Over 5 years, FCF Margin stood at 53.25% in 2021, then jumped by 250 bps to 79.65% in 2022, then plunged by 199 bps to 78.61% in 2023, then jumped by 33 bps to 52.45% in 2024, then surged by 90 bps to 5.18% in 2025.
• According to Business Quant data, FCF Margin over the past three periods registered 5.18%, 36.06%, and 60.99% for Q4 2025, Q3 2025, and Q2 2025 respectively.